Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
St James’s Hospital Dublin, a public healthcare provider, is procuring a digital PCR platform for its Cancer Molecular Diagnostics Department, together with associated reagents, consumables and support. The contract covers one complete digital PCR instrument with all hardware, software and ancillary equipment needed for routine operation, plus installation, commissioning, training and a minimum three-year comprehensive warranty. The supplier must provide an agreed initial quantity or value of development reagents and consumables, with further stock available for laboratory draw-down as required during the three-year agreement; the hospital may also use the platform to develop assays or transfer selected molecular diagnostic assays to digital PCR where clinically, analytically or operationally justified. The estimated contract value is £250,000 over three years, with delivery at St James’s Hospital in Dublin, Ireland. The critical qualification requirement is the ability to supply, install, commission, train users on and comprehensively warrant a complete digital PCR system for routine molecular diagnostics.
Buyer: St James's Hospital. Source: eTenders Ireland. Updated 9 Oct 2026.
Key facts
- Estimated value: €250k
- Bids close: 10 Nov 2026
- Location: Ireland
- Procedure: Open
- Category: Laboratory, optical and precision equipments (excl. glasses) (38000000)
From the official notice
The Contracting Authority (CA) seeks to purchase one digital PCR instrument, including all hardware, software and ancillary equipment required for routine operation. The purchase shall include a minimum three-year comprehensive warranty, installation, commissioning and training.The CA intends initially to use the platform for assay development, evaluation and method transfer and wishes to purchase an agreed quantity/value of development reagents and consumables at the commencement of the contract. These reagents shall be available for draw-down by the laboratory as required over the three-year agreement. During the course of the agreement, the CA may elect to develop new assays or migrate selected existing molecular diagnostic assays to dPCR where this provides appropriate clinical, analytical or operational benefit. The extent and timing of such migration will be determined by the CA according to clinical and service requirements and does not represent a commitment to implement any specific assay or purchase any minimum quantity of reagents.
View the official notice
Questions about this tender
When is the deadline?
Bids close on 10 Nov 2026.
What is it worth?
The estimated value is €250k.
Who can apply?
Any supplier that meets the buyer's requirements can apply. Check the official notice for conditions.
How do I bid?
Open the official notice, register on the buyer's portal and submit your bid before the deadline.
Similar tenders
Contains public sector information licensed under the Open Government Licence v3.0.
See all live tenders